Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synaptic Signaling01:12

Synaptic Signaling

79.7K
Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
79.7K
Synaptic Signaling01:09

Synaptic Signaling

6.7K
Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
Most synapses are chemical, meaning an electrical impulse or action potential spurs the release of chemical messengers called neurotransmitters. The neuron sending the signal is called the presynaptic neuron, and the neuron receiving the signal is the postsynaptic neuron.
The presynaptic neuron fires an action potential that...
6.7K
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Reaction Mechanisms03:06

Reaction Mechanisms

30.9K
Chemical reactions often occur in a stepwise fashion, involving two or more distinct reactions taking place in a sequence. A balanced equation indicates the reacting species and the product species, but it reveals no details about how the reaction occurs at the molecular level. The reaction mechanism (or reaction path) provides details regarding the precise, step-by-step process by which a reaction occurs.
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
30.9K
Integration of Synaptic Events01:28

Integration of Synaptic Events

4.1K
Synaptic integration mainly includes the summation of graded potentials. Graded potentials, regardless of their type, cause subtle alterations in membrane voltage, resulting in either depolarization or hyperpolarization. These incremental changes, when combined or summed, can propel the neuron toward its threshold. Consider, for example, a membrane experiencing a +15 mV shift, causing it to depolarize from -70 mV to -55 mV. In this scenario, graded potentials govern the membrane's ability to...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tibetan Tea Alleviates the Intestinal Dysfunction in Sleep-Deprived Mice Through Regulating Oxidative Stress and Inflammation-Related Intestinal Metabolisms.

Molecular nutrition & food research·2025
Same author

Transcriptomic analysis of wrinkled leaf development of Tai-cai (Brassica rapa var. tai-tsai) and its synthetic allotetraploid via RNA and miRNA sequencing.

Plant molecular biology·2025
Same author

Intelligent identification method of origin for Alismatis Rhizoma based on image and machine learning.

Scientific reports·2025
Same author

Associations between skeletal muscle strength and chronic kidney disease in patients with MASLD.

Communications medicine·2025
Same author

Global Scientific Trends in the Use Of Mesenchymal Stem Cells for the Treatment of Diabetes Mellitus from 2000 to 2023: A Bibliometric Study.

Endocrine, metabolic & immune disorders drug targets·2025
Same author

Sex-Specific Association between Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes: A Post-Hoc Analysis of the SPRINT Trial.

Reviews in cardiovascular medicine·2025

Related Experiment Video

Updated: Feb 6, 2026

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
10:05

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

7.5K

[Progress in synaptic mechanism in epileptogenesis].

Xiuzhen Xiao1, Yuanhan Ouyang2, Zhi Song2

  • 1Department of Nursing, Third Xiangya Hospital, Central South University, Changsha 410013, China.

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|August 30, 2018
PubMed
Summary
This summary is machine-generated.

Recurrent seizures alter synaptic proteins, contributing to epilepsy. New antiepileptic drugs target synaptic vesicle protein 2A, offering novel treatment strategies for seizure disorders.

More Related Videos

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents
07:58

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents

Published on: September 15, 2011

9.8K
Studying Synaptic Vesicle Pools using Photoconversion of Styryl Dyes
08:46

Studying Synaptic Vesicle Pools using Photoconversion of Styryl Dyes

Published on: February 15, 2010

12.2K

Related Experiment Videos

Last Updated: Feb 6, 2026

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
10:05

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

7.5K
Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents
07:58

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents

Published on: September 15, 2011

9.8K
Studying Synaptic Vesicle Pools using Photoconversion of Styryl Dyes
08:46

Studying Synaptic Vesicle Pools using Photoconversion of Styryl Dyes

Published on: February 15, 2010

12.2K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • Recurrent seizures disrupt normal synaptic function, leading to abnormal neural networks.
  • Synaptic proteins are increasingly recognized as key players in the development of epilepsy (epileptogenesis).
  • Dysregulation of synaptic regulatory and postsynaptic membrane receptor proteins can contribute to seizure disorders.

Purpose of the Study:

  • To explore the role of synaptic proteins in epileptogenesis.
  • To identify the mechanisms of action for existing and novel antiepileptic drugs.
  • To highlight synaptic vesicle protein 2A as a therapeutic target.

Main Methods:

  • Review of current literature on synaptic proteins and epilepsy.
  • Analysis of drug-target interactions for antiepileptic medications.
  • Identification of molecular targets for novel antiepileptic therapies.

Main Results:

  • Abnormal expression and reorganization of synaptic proteins are hallmarks of recurrent seizures.
  • Ion channels are primary targets for many antiepileptic drugs.
  • Carbamazepine and zonisamide may target syntaxin and/or SNARE complexes.
  • Synaptic vesicle protein 2A is identified as the target for newer antiepileptic drugs like levetiracetam.

Conclusions:

  • Synaptic protein dysregulation is implicated in the pathophysiology of epilepsy.
  • Targeting synaptic proteins offers promising avenues for epilepsy treatment.
  • Synaptic vesicle protein 2A represents a key target for next-generation antiepileptic drug development.